19 December 2017 

Review Paper

Yook-Chin Chia MBBS, FRCP1,2 | Peera Buranakitjaroen MD, MSc, DPhil3 | Chen-Huan Chen MD4 | Romeo Divinagracia MD, MHSA5 | Satoshi Hoshide MD, PhD6 | Sungha Park MD, PhD7 | Jinho Shin MD8 | Saulat Siddique MBBS, MRCP(UK), FRCP(Lon)9 | Jorge Sison MD10 | Arieska Ann Soenarta MD11 | Guru Prasad Sogunuru MD, DM12,13 | Jam Chin Tay MBBS, FAMS14 | Yuda Turana MD, PhD15 | Ji-Guang Wang MD, PhD16 | Lawrence Wong MD17 | Yuqing Zhang MD18 | Kazuomi Kario MD, PhD6 On behalf of the HOPE Asia Network


Hypertension represents a major burden in Asia, with a high prevalence rate but poor level of awareness and control reported in many countries in the region. Home blood pressure monitoring has been validated as an accurate and reliable measure of blood pressure that can help guide hypertension treatment as well as identify masked and white-coat hypertension. Despite its benefits, there has been limited research into home blood pressure monitoring in Asia. The authors reviewed the current evidence on home blood pressure monitoring in Asia, including but not limited to published literature, data presented at congresses, and national hypertension management guidelines to determine the current utilization of home blood pressure monitoring in clinical practice in the region. Public policies to enable greater access to home blood pressure monitoring and its use in clinical care would add considerably to improving hypertension outcomes in Asia.